Ventyx Biosciences
VTYX
VTYX
138 hedge funds and large institutions have $1.9B invested in Ventyx Biosciences in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 61 increasing their positions, 44 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
9% less call options, than puts
Call options by funds: $9.34M | Put options by funds: $10.3M
8% less funds holding
Funds holding: 150 → 138 (-12)
43% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 23
Holders
138
Holding in Top 10
3
Calls
$9.34M
Puts
$10.3M
Top Buyers
| 1 | +$31.1M | |
| 2 | +$17.3M | |
| 3 | +$13.9M | |
| 4 |
VP
venBio Partners
San Francisco,
California
|
+$11.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.65M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$20.2M | |
| 3 | -$11.7M | |
| 4 |
HSBC Holdings
London,
United Kingdom
|
-$8.23M |
| 5 |
Morgan Stanley
New York
|
-$7.99M |